USF Health

The trials here

What the 14 trials at this site are about, from their registry records.

Conditions

• Epilepsy2 trials
• Migraine2 trials
• Asthma1 trial
• Atopic dermatitis (eczema)1 trial
• Atrial fibrillation1 trial
• Crohn's disease1 trial
• Depression1 trial
• Heart failure1 trial
• Lupus (SLE)1 trial
• Multiple sclerosis1 trial
• Psoriasis1 trial
• Vitiligo1 trial

Phase

• Phase 35 trials
• Phase 23 trials
• Phase 2/31 trial

Status

• Recruiting7 trials
• Active, not recruiting6 trials
• Terminated1 trial

Lead sponsor

• Eli Lilly and Company4 trials
• Epiminder America, Inc.2 trials
• Pfizer2 trials
• Abbott Medical Devices1 trial
• Bristol-Myers Squibb1 trial
• and 4 more

Running trials

• Recruiting

  Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up

  NCT07110454· Epiminder America, Inc.· Source

  Contact: Marina Azevedo

• Recruiting

  Diagnosing Epilepsy To EffeCT Change

  NCT07110337· Epiminder America, Inc.· Source

  Contact: Marina Azevedo

• Recruiting

  A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

  NCT06979453· Phase 3· Bristol-Myers Squibb· Source

  Contact: Sharon Albers, Site 0171

• Recruiting

  A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

  NCT07219173· Phase 2· Eli Lilly and Company· Source

  Contact: Thomas Casale (principal investigator)

• Active, not recruiting

  A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

  NCT07015983· Phase 2· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Source

• Recruiting

  Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study

  NCT06935591· Vektor Medical· Source

  Contact: Jacky He

• Recruiting

  A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

  NCT06782490· Phase 2· Celgene· Source

  Contact: Derrick Robertson, Site 0015

• Recruiting

  Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

  NCT06423430· Abbott Medical Devices· Source

  Contact: Yvonne Bannon

• Active, not recruiting

  A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2

  NCT06072183· Phase 3· Pfizer· Source

• Active, not recruiting

  A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine

  NCT04616326· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

  NCT04232553· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  PROACTIVE-HF IDE Trial Heart Failure NYHA Class III

  NCT04089059· Endotronix, Inc.· Source

• Active, not recruiting

  A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine

  NCT03432286· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Epilepsy2 recruiting
• Asthma1 recruiting
• Atrial fibrillation1 recruiting
• Depression1 recruiting
• Multiple sclerosis1 recruiting
• Psoriasis1 recruiting

Closed trials

• Terminated

  A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection

  NCT05732454· Phase 2/3· Pfizer· Source